Asbury (ABG) director reports 800-share sale at $255.61

Rhea-AI Filing Summary

Insider sale by Asbury Automotive Group director. Maureen F. Morrison, a director of Asbury Automotive Group (ABG), reported selling 800 shares of the issuer's common stock on 08/28/2025 at a reported price of $255.61 per share. After the sale she beneficially owned 5,824 shares. The Form 4 was signed on behalf of the reporting person by Dean Calloway, Attorney-in-Fact, dated 09/02/2025. The filing discloses a single non-derivative sale transaction; no additional transactions or derivative holdings are reported.

Insights

Financial Analyst

TL;DR: Routine insider sale reported; single small transaction disclosed, neutral investor impact.

The Form 4 documents a one-time sale of 800 common shares by a company director at $255.61 each, leaving 5,824 shares beneficially owned. From a financial perspective, this is a straightforward disclosure of insider liquidity rather than an operational development: it does not include any material corporate events, derivative activity, or changes to compensation arrangements. Without further context on average insider activity or proportional ownership, this transaction alone is neutral for valuation models.

Corporate Governance Expert

TL;DR: Filing appears timely and properly executed by attorney-in-fact; documents a standard Section 16 sale.

The Form 4 indicates the reporting person is a director and that the report was filed by one reporting person. The report is signed by an attorney-in-fact, which is a common procedural practice. There are no disclosures of 10b5-1 plans, amendments, or indirect ownership structures in this filing. Governance-wise, the form meets basic disclosure requirements for an insider sale but does not provide additional governance signals.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morrison Maureen F

(Last) (First) (Middle)

C/O ASBURY AUTOMOTIVE GROUP, INC.

2905 PREMIERE PKWY, STE 300

(Street)

DULUTH GA 30097

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ASBURY AUTOMOTIVE GROUP INC [ ABG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/28/2025		S		800	D	$255.61	5,824	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/Dean Calloway, Attorney In-Fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ABG director Maureen F. Morrison report?

The director reported a sale of 800 shares of Asbury Automotive Group common stock on 08/28/2025 at a reported price of $255.61 per share.

How many Asbury (ABG) shares does Maureen Morrison beneficially own after the transaction?

Following the reported sale, she beneficially owned 5,824 shares according to the Form 4.

Who signed the Form 4 for the ABG insider filing and when?

The Form 4 was signed by /s/Dean Calloway, Attorney In-Fact with a signature date of 09/02/2025.

Does the Form 4 disclose any derivative securities or 10b5-1 plan?

No. The filing shows only a non-derivative sale of common stock and does not indicate any derivative holdings or mention a 10b5-1 trading plan.

Is this Form 4 filed by more than one reporting person?

No. The filing indicates it was filed by one reporting person.